Sequana Medical haalt €27,5 miljoen op in succesvolle Eerste Openbaar Aanbod
February 08, 2019 12:32 ET
|
Sequana Medical
Een belegging in de Aangeboden Aandelen houdt substantiële risico's en onzekerheden in. Potentiële beleggers moeten het gehele Prospectus lezen dat werd voorbereid door de Vennootschap, en moeten in...
Sequana Medical raises €27.5 million in successful Initial Public Offering
February 08, 2019 12:32 ET
|
Sequana Medical
An investment in the Offered Shares involves substantial risks and uncertainties. Prospective investors should read the entire Prospectus that has been prepared by the Company, and, in particular,...
Sequana Medical kondigt de Volledige Intekening aan op de Basisaanbieding van haar Eerste Openbaar Aanbod ("Initial Public Offering") op Euronext Brussels
February 07, 2019 09:25 ET
|
Sequana Medical
Een belegging in de Aangeboden Aandelen houdt substantiële risico's en onzekerheden in. Potentiële beleggers moeten het gehele Prospectus lezen dat werd voorbereid door de Vennootschap, en moeten in...
Sequana Medical announces the Coverage of the Base Offering of Its Initial Public Offering on Euronext Brussels
February 07, 2019 09:25 ET
|
Sequana Medical
An investment in the Offered Shares involves substantial risks and uncertainties. Prospective investors should read the entire Prospectus that has been prepared by the Company, and, in particular,...
Sequana Medical Lanceert haar Eerste Openbaar Aanbod ("Initial Public Offering") op Euronext Brussels
January 31, 2019 01:00 ET
|
Sequana Medical
Een belegging in de Aangeboden Aandelen houdt substantiële risico's en onzekerheden in. Potentiële beleggers moeten het gehele Prospectus lezen dat werd voorbereid door de Vennootschap, en moeten in...
Sequana Medical Launches Its Initial Public Offering on Euronext Brussels
January 31, 2019 01:00 ET
|
Sequana Medical
An investment in the Offered Shares involves substantial risks and uncertainties. Prospective investors should read the entire Prospectus that has been prepared by the Company, and, in particular,...
Sequana Medical establishes new corporate headquarters in Ghent, Belgium and raises €8.5 million from leading Belgian investors including Newton Biocapital, PMV and SFPI-FPIM as well as existing shareholders
October 15, 2018 01:00 ET
|
Sequana Medical
Press Release Sequana Medical establishes new corporate headquarters in Ghent, Belgium and raises €8.5 million from leading Belgian investors includingNewton Biocapital, PMV and SFPI-FPIM as well as...
Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients at the International Gynecologic Cancer Society
September 17, 2018 07:00 ET
|
Sequana Medical
Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients at the International Gynecologic Cancer Society Data also to be presented at the 68th...